MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Astrazeneca Pharma India Limited

L24231KA1979PLC003563ActivePublic · Non-govt companyRoC-BangaloreListed
Last updated: 2026-06-08
100
Compliance Health · A · provisional
4 / 4 signals passed

Astrazeneca Pharma India Limited is a Public Non-govt company company incorporated in 1979 and based in Karnataka, India. Astrazeneca Pharma India Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹5.00 Cr and paid-up capital of ₹5.00 Cr. For 2025-26, the company reported revenue of ₹2275.58 Cr and profit after tax of ₹187.52 Cr. The board has 4 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.

Risk FlagsAGM 1849d ago · may be overdue
Revenue (latest FY)
₹2275.58 Cr
2025-26
PAT (latest FY)
₹187.52 Cr
Margin 8.2%
Open Charges
0
No encumbrances
Active Directors
4
No resignations
Paid-up Capital
₹5.00 Cr
100% of authorized
Filings on Record
0
All current
Incorporated
1979
47 years old
State
Karnataka
Sector
Chemical substances used in the manufacture of anti-biotic, manufacturing
NIC 24231
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹5.00 Cr
Paid-up Capital
₹5.00 Cr
100% utilized
Members
—
Last AGM
09 Aug 2021
1849d ago
Last Balance Sheet
31 Mar 2021
1980d ago
Latest Filing
—
Registered Email
c********(at)astrazeneca.com
Registered Office
BLOCK N1, 12TH FLOOR,MANYATA EMBASSY BUSINESS PARK RACHENAHALLI, OUTER RING ROAD BANGALORE Bangalore KA 560045 IN
ASTRAZENECA PHARMA INDIA LIMITED
Brand ASTRAZENECA PHARMA INDIA LIMITED · Legal entity Astrazeneca Pharma India Limited

ASTRAZENECA PHARMA INDIA LIMITED is the legal entity of Astrazeneca.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
58
Stage
Public
HQ
—
Founded
1979
Joined to MCA on CIN L24231KA1979PLC003563

Quick facts

Identity · Activity · Auditor · Contact
Registered office
BLOCK N1, 12TH FLOOR,MANYATA EMBASSY BUSINESS PARK RACHENAHALLI, OUTER RING ROAD BANGALORE Bangalore KA 560045 IN
NIC code
24231
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
c********(at)astrazeneca.com
Section
Chemical substances used in the manufacture of anti-biotic, manufacturing
ROC
RoC-Bangalore
Website
—
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
11 Jul 1979 · 09 Aug 2021

Directors

4 activeNo resignations on record
S
Shilpa
Director
4.7y · Mumbai · DIN 6619353 · 1 other co.
A
Ankush
Director
6.1y · NORTHWOOD · DIN 8737981
W
Weiying
Director
7.1y · Shanghai · DIN 8369289
G
Gagandeep
Director
9.2y · Bangalore · DIN 7844333 · 2 other co.

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 2024+24dfiled
MGT-7FY2024-2521 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+7dfiled
MGT-7FY2023-2427 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2322 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Astrazeneca Pharma India Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
960346079Kotak Mahindra Bank Ltd(Bank)₹17.74 Cr12 Mar 2019Satisfied
562510887Kotak Mahindra Bank Ltd(Bank)₹24.12 Cr27 Jan 2023Open
541729937HDFC Bank Ltd(Bank)₹9.52 Cr19 Sep 2020Open
467235533HDFC Bank Ltd(Bank)₹13.58 Cr12 Mar 2022Open
392878735Axis Bank Ltd(Bank)₹5.38 Cr27 Jan 2020Open
See registered charges & lenders

Charge IDs, lenders & amounts for Astrazeneca Pharma India Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

MCA1 reporting year
Revenue (bars) vs PAT (line) by FY
Revenue PAT
₹0₹744.59 Cr₹1489.19 Cr₹2233.78 Cr₹2127.41 Cr2025-26
FYRevenuePATNet WorthTotal AssetsEmployees
2025-26—

Detailed Financials

1 FYsIncome statement + balance sheet
Line item2025-26
Income statement
Revenue from operations
Other income
Total income
Total expenses
Profit before tax
Profit / (Loss) after tax
Balance sheet
Equity / Net worth
Borrowings
Current liabilities
Total liabilities
Current assets
Cash & equivalents
Total assets
Employees—

Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹63.21 Cr+32.0%+12.2%-1.1%
Profit after Tax₹10.59 Cr-2.5%-3.2%+11.6%
Net Worth₹58.40 Cr+0.4%+8.4%+16.6%
Employees257+24.0%+25.7%+18.7%
Gain deeper financial insights of this entity

Audited financials & ratios for Astrazeneca Pharma India Limited.

₹999₹249(excl. taxes)
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiency
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
2025-26+8.24%————

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters32,73,41,92362.66%
Institutional Investors39,43,1272.16%
Public & Others391,53,50,92035.18%
See the full shareholding pattern

Promoter, institutional & public holding for Astrazeneca Pharma India Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

228 peersSame sector (Chemical substances used in the manufacture of anti-biotic, manufacturing) — nationwide
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Top quartile · P99
PAT (latest FY)
Top quartile · P99
Employees
—
—
—
—
Paid-up capital
Top quartile · P86
Compliance Health
96
96
96
Bottom quartile · P0

Top 10 in Chemical substances used in the manufacture of anti-biotic, manufacturing

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Pfizer Limited
Maharashtra · Inc 1950
Paid-up
Revenue
A · 96
03
Heranba Industries Limited
Gujarat · Inc 1992
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Indus Biotech Limited
Maharashtra · Inc 1995
Paid-up
Revenue
A · 96
06
Paid-up
Revenue
A · 96
07
Venlon Enterprises Limited
Karnataka · Inc 1983
Paid-up
Revenue
A · 96
08
Nasense Labs Private Limited
Telangana · Inc 1995
Paid-up
Revenue
A · 96
09
Fil Industries Private Limited
Jammu & Kashmir · Inc 1989
Paid-up
Revenue
A · 96
10
Mdc Pharmaceuticals Limited
Chandigarh · Inc 1994
Paid-up
Revenue
A · 96

Events & timeline

5Filings, charges, board changes
29 Dec 2021
Shilpa appointed as Director
10 Aug 2020
Ankush appointed as Director
07 Aug 2019
Weiying appointed as Director
01 Jul 2017
Gagandeep appointed as Director
11 Jul 1979
Company incorporated
Astrazeneca Pharma India Limited registered with RoC-Bangalore; year 1979

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Astrazeneca Pharma India Limited

When was Astrazeneca Pharma India Limited incorporated?
Astrazeneca Pharma India Limited was incorporated in 1979 (around 11 Jul 1979). Its CIN is L24231KA1979PLC003563 and it is registered with RoC-Bangalore.
Where is Astrazeneca Pharma India Limited located?
Astrazeneca Pharma India Limited is headquartered in Karnataka, at: BLOCK N1, 12TH FLOOR,MANYATA EMBASSY BUSINESS PARK RACHENAHALLI, OUTER RING ROAD BANGALORE Bangalore KA 560045 IN .
What sector does Astrazeneca Pharma India Limited operate in?
Astrazeneca Pharma India Limited operates in the Chemical substances used in the manufacture of anti-biotic, manufacturing sector (NIC code 24231), classified as Non-govt company.
Who are the directors of Astrazeneca Pharma India Limited?
Astrazeneca Pharma India Limited has 4 active directors: Shilpa (Director), Ankush (Director), Weiying (Director), Gagandeep (Director).
What is the paid-up capital of Astrazeneca Pharma India Limited?
Astrazeneca Pharma India Limited has authorized capital of ₹5.00 Cr and paid-up capital of ₹5.00 Cr.
Does Astrazeneca Pharma India Limited have any open charges?
Astrazeneca Pharma India Limited has no open MCA-registered charges on record.
What is Astrazeneca Pharma India Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Astrazeneca Pharma India Limited is 100/100 (grade A), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 4 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.